Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention

Abstract

Numerous laboratory and epidemiologic studies strongly implicate endogenous and exogenous estrogens in the etiology of breast cancer. Data summarized herein suggest that the ACI rat model of 17β-estradiol (E2)-induced mammary cancer is unique among rodent models in the extent to which it faithfully reflects the etiology and biology of luminal types of breast cancer, which together constitute ~70% of all breast cancers. E2 drives cancer development in this model through mechanisms that are largely dependent upon estrogen receptors and require progesterone and its receptors. Moreover, mammary cancer development appears to be associated with generation of oxidative stress and can be modified by multiple dietary factors, several of which may attenuate the actions of reactive oxygen species. Studies of susceptible ACI rats and resistant COP or BN rats provide novel insights into the genetic bases of susceptibility and the biological processes regulated by genetic determinants of susceptibility. This review summarizes research progress resulting from use of these physiologically relevant rat models to advance understanding of breast cancer etiology and prevention.

Document Details

Document Type
Pub Defense Publication
Publication Date
Mar 01, 2018
Source ID
10.1152/physiolgenomics.00105.2017

Entities

People

  • Aaron C. Chack
  • Amy Trentham-dietz
  • James Shull
  • Kirsten L. Dennison

Organizations

  • Congressionally Directed Medical Research Programs
  • National Cancer Institute
  • National Institute of Environmental Health Sciences
  • Susan G. Komen for the Cure
  • University of Wisconsin–Madison

Tags

Fields of Study

  • Biology

Readers

  • Breast cancer cell signaling and growth regulation.
  • Computational Modeling and Simulation
  • Molecular and genetic basis of cancer.

Technology Areas

  • Biotechnology